Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - December 2012


Oral Solid Dosage Manufacturing Technology (1 day)

14 Dec 2012 - 14 Dec 2012 - Window Conference Venue, 13 Windsor Street, Islington, London, N1 8QG



Bookmark and Share


Oral Solid dosage forms as Tablets and Capsules, are some of the most convenient and most used methods of drug delivery.
This 1-day interactive workshop is intended to provide an understanding of the fundamentals of Oral Solid Dosage manufacture and to highlight the dependency between the various process steps.

Some of the benefits to be derived from this workshop include:

• An understanding of the basics of the Tablet Making Process.
• An appreciation of the demands of the new production environment
• An appreciation of the individual’s role in improving quality at all process stages
• A knowledge of “how things work” and how this may help in trouble shooting & fixing problems

Course Leader:
Mike Cliff is an independent training consultant specialising in the area of oral solid dosage
manufacturing technology. Mike has been a regular presenter at courses and training events
in his 34 year association with the process industries.

Who should attend?
Pharmaceutical facility manufacturing staff and maintenance staff.
Quality Assurance staff, Regulatory staff, Engineering staff, Project Managers and
anybody else involved in operations peripheral to manufacturing who require an
understanding of the basic process operations.

Course Programme

Morning session
• Introduction
• Tablet Formulation
• Impact of Powders Characteristics on Formulation Properties
• Tablet Manufacturing Process
• Dispensing
• Granulation
• Drying
• Dry Milling (Dry Granulation)

Afternoon session
• Blending
• Tablet Compression
• Coating
• Encapsulation
• Warehousing and Quarantine



Further information
Scientific News
Spero Therapeutics Announces $30 Million Series B Preferred Financing
Company has announced financing of $30 million to support development of novel therapies to treat gram-negative bacterial infections.
Keeping Tumor Growth at Bay
Engineers at Washington University in St. Louis found a way to keep a cancerous tumor from growing by using nanoparticles of the main ingredient in common antacid tablets.
Future of Medicine Could be Found in a Tiny Crystal Ball
A Drexel University materials scientist has discovered a way to grow a crystal ball in a lab. Not the kind that soothsayers use to predict the future, but a microscopic version that could be used to encapsulate medication in a way that would allow it to deliver its curative payload more effectively inside the body.
Improving Delivery of Poorly Soluble Drugs Using Nanoparticles
A technology that could forever change the delivery of drugs is undergoing evaluation by the Technology Evaluation Consortium™ (TEC). Developed by researchers at Northeastern University, the technology is capable of creating nanoparticle structures that could deliver drugs into the bloodstream orally – despite the fact that they are normally poorly soluble.
Faster Drug Discovery?
Startup develops more cost-effective test for assessing how cells respond to chemicals.
New Mechanism of Antitumor Action Identified
A team of UAB researchers and collaborators from the Catalan biotech company Ability Pharmaceuticals (UAB Research Park), have described a new mechanism of anti-tumour action, identified during the study and development of the new drug ABTL0812.
Nanoparticles Deliver Tumor Suppressors to Damaged Livers
UT Southwestern Medical Center chemists have successfully used synthetic nanoparticles to deliver tumor-suppressing therapies to diseased livers with cancer, an important hurdle scientists have been struggling to conquer.
Experimental Combination Surprises with Anti-HIV Effectiveness
A compound developed to protect the nervous system from HIV surprised researchers by augmenting the effectiveness of an investigational antiretroviral drug beyond anything expected.
A New Type of Anticancer Agent
Success in the development of a ?-tubulin specific inhibitor.
Nanoparticles Proven Effective Against Antibiotic-Resistant “Superbugs”
In the ever-escalating evolutionary battle with drug-resistant bacteria, humans may soon have a leg up thanks to adaptive, light-activated nanotherapy developed by researchers at the University of Colorado Boulder.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!